Search PDMR transactions

Notifier
Name of person with notification obligation
Richard Godfrey
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Richard Godfrey
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
IRLAB Therapeutics AB
Issuer´s LEI code
549300JAT34LHEI0DH60
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 5,000 Quantity 34.8914 SEK 01/09/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 01/09/2022 NASDAQ STOCKHOLM AB 5,000 (Quantity) 34.8914 SEK
<< Back